KETOCONAZOLE- ketoconazole tablet

Šalis: Jungtinės Valstijos

kalba: anglų

Šaltinis: NLM (National Library of Medicine)

Veiklioji medžiaga:

KETOCONAZOLE (UNII: R9400W927I) (KETOCONAZOLE - UNII:R9400W927I)

Prieinama:

NuCare Pharmaceuticals, Inc.

INN (Tarptautinis Pavadinimas):

KETOCONAZOLE

Sudėtis:

KETOCONAZOLE 200 mg

Vartojimo būdas:

ORAL

Recepto tipas:

PRESCRIPTION DRUG

Terapinės indikacijos:

Ketoconazole tablets USP, 200 mg should be used only when other effective antifungal therapy is not available or tolerated and the potential benefits are considered to outweigh the potential risks. Ketoconazole tablets USP, 200 mg are indicated for the treatment of the following systemic fungal infections in patients who have failed or who are intolerant to other therapies: blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. Ketoconazole tablets USP, 200 mg should not be used for fungal meningitis because it penetrates poorly into the cerebrospinal fluid. Coadministration of a number of CYP3A4 substrates such as dofetilide, quinidine cisapride and pimozide is contraindicated with ketoconazole tablets. Coadministration with ketoconazole can cause elevated plasma concentrations of these drugs and may increase or prolong both therapeutic and adverse effects to such an extent that a potentially serious adverse reaction may occur. For example, increased plasma concentratio

Produkto santrauka:

Ketoconazole tablets USP, 200 mg are white to off-white round, flat tablets, one side scored and engraved with "T" above the score and "57" below the score. The other side is plain. They are supplied in bottles of 30 NDC 68071-4012-03 Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Protect from moisture. Keep out of reach of children.

Autorizacija statusas:

Abbreviated New Drug Application

Pakuotės lapelis

KETOCONAZOLE- KETOCONAZOLE TABLET
NuCare Pharmaceuticals, Inc.
----------
MEDICATION GUIDE
Ketoconazole
(KEE-toe-KON-a-zole)
Tablets USP, 200 mg
What is the most important information I should know about
ketoconazole tablets USP?
Ketoconazole tablets is not the only medicine available to treat
fungal infections and should only be used
when other medicines are not right for you. Talk to your healthcare
provider to find out if ketoconazole
tablets are right for you.
Ketoconazole tablets USP can cause serious side effects, including:
•
liver problems (hepatotoxicity). Some people who were treated with
ketoconazole the active
ingredient in ketoconazole tablets, had serious liver problems that
led to death or the need for a
liver transplant. Call your healthcare provider right away if you have
any of the following
symptoms:
•
loss of appetite or start losing weight (anorexia)
•
nausea or vomiting
•
feel tired
•
stomach pain or tenderness
•
dark urine or light colored stools
•
yellowing of your skin or the whites of your eyes
•
fever or rash
•
changes in the electrical activity of your heart called QT
prolongation. QT prolongation can cause
irregular heart beats that can be life threatening. This can happen
when ketoconazole tablets are
taken with certain medicines, such as dofetilide, quinidine, pimozide,
cisapride, methadone,
disopyramide, dronedarone, and ranolazine. Talk to your healthcare
provider about other
medicines you are taking before you start taking ketoconazole tablets.
Tell your healthcare
provider right away if you feel faint, lightheaded, dizzy, or feel
your heart beating irregularly or
fast. These may be symptoms related to QT prolongation.
What are ketoconazole tablets USP?
•
Ketoconazole tablets are prescription medicine used to treat serious
fungal infections including:
blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and
paracoccidioidomycosis.
•
Ketoconazole tablets are not for people with fungal nail infections.
•
Ketoconazole tablets have not been approv

Prekės savybės

KETOCONAZOLE- KETOCONAZOLE TABLET
NUCARE PHARMACEUTICALS, INC.
----------
KETOCONAZOLE
TABLETS USP,
200 MG
RX ONLY
WARNING
Ketoconazole tablets USP, 200 mg should be used only when other
effective antifungal therapy is
not available or tolerated and the potential benefits are considered
to outweigh the potential risks.
HEPATOTOXICITY
Serious hepatotoxicity, including cases with a fatal outcome or
requiring liver transplantation has
occurred with the use of oral ketoconazole. Some patients had no
obvious risk factors for liver
disease. Patients receiving this drug should be informed by the
physician of the risk and should be
closely monitored. See WARNINGS section.
QT PROLONGATION AND DRUG INTERACTIONS LEADING TO QT PROLONGATION
Co-administration of the following drugs with ketoconazole is
contraindicated: dofetilide,
quinidine, pimozide, cisapride, methadone, disopyramide, dronedarone,
ranolazine. Ketoconazole
can cause elevated plasma concentrations of these drugs and may
prolong QT intervals,
sometimes resulting in life-threatening ventricular dysrhythmias such
as torsades de pointes. See
CONTRAINDICATIONS, WARNINGS, and PRECAUTIONS: Drug Interactions
sections.
DESCRIPTION
Ketoconazole tablets USP is a synthetic broad-spectrum antifungal
agent available in scored white
tablets, each containing 200 mg ketoconazole base for oral
administration. Inactive ingredients are
colloidal silicon dioxide, corn starch, lactose monohydrate, magnesium
stearate, microcrystalline
cellulose, and povidone. Ketoconazole is
cis-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-
ylmethyl)-1,3-dioxolan-4-yl] methoxyl]phenyl] piperazine and has the
following structural formula:
Ketoconazole is a white to slightly beige, odorless powder, soluble in
acids, with a molecular weight
of 531.44.
CLINICAL PHARMACOLOGY
PHARMACOKINETICS
Absorption
Ketoconazole is a weak dibasic agent and thus requires acidity for
dissolution and absorption.
Mean peak plasma concentrations of approximately 3.5 μg/mL are
reached within 1 to 2 hours,
follow